- Home
- SBFM vs MSDL Comparison
SBFM vs MSDL Comparison
Compare SBFM & MSDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MSDL
- Stock Information
- Founded
- SBFM 2006
- MSDL 2019
- Country
- SBFM United States
- MSDL United States
- Employees
- SBFM N/A
- MSDL N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MSDL
- Sector
- SBFM Health Care
- MSDL
- Exchange
- SBFM Nasdaq
- MSDL NYSE
- Market Cap
- SBFM 4.9M
- MSDL N/A
- IPO Year
- SBFM N/A
- MSDL N/A
- Fundamental
- Price
- SBFM $1.51
- MSDL $19.32
- Analyst Decision
- SBFM Strong Buy
- MSDL Hold
- Analyst Count
- SBFM 1
- MSDL 6
- Target Price
- SBFM $15.00
- MSDL $20.40
- AVG Volume (30 Days)
- SBFM 4.3M
- MSDL 636.1K
- Earning Date
- SBFM 05-19-2025
- MSDL 01-01-0001
- Dividend Yield
- SBFM N/A
- MSDL 10.35%
- EPS Growth
- SBFM N/A
- MSDL N/A
- EPS
- SBFM N/A
- MSDL N/A
- Revenue
- SBFM $34,874,283.00
- MSDL N/A
- Revenue This Year
- SBFM $192.48
- MSDL $1,597.39
- Revenue Next Year
- SBFM N/A
- MSDL $15.10
- P/E Ratio
- SBFM N/A
- MSDL N/A
- Revenue Growth
- SBFM 44.75
- MSDL N/A
- 52 Week Low
- SBFM $1.17
- MSDL $17.59
- 52 Week High
- SBFM $33.60
- MSDL $24.18
- Technical
- Relative Strength Index (RSI)
- SBFM 43.22
- MSDL 47.65
- Support Level
- SBFM $1.17
- MSDL $18.90
- Resistance Level
- SBFM $1.59
- MSDL $19.97
- Average True Range (ATR)
- SBFM 0.17
- MSDL 0.61
- MACD
- SBFM 0.04
- MSDL 0.10
- Stochastic Oscillator
- SBFM 70.89
- MSDL 72.69
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.